TrialCephalalgia : an international journal of headache2022

Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2.

Messoud Ashina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.